Publications by authors named "Bixing Zhao"

Claim this Profile
D
DGKH-PA-mTOR: A pharmacologically druggable metabolic axis underpinning tyrosine-kinase-inhibitor resistance in hepatocellular carcinoma.
Feifan Cai, Bixing Zhao

ILIVER· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia-induced exosomal LUCAT1 promotes osimertinib resistance in lung adenocarcinoma by stabilizing c-MET.
Jianting Du, Bin Zheng, Jiekun Qian, Guanglei Huang, Wenjie Yuan, Bixing Zhao

Cell Death Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of artificial circular RNAs as miRNA sponges and anti-PD-1 scFv expression platforms to suppress hepatocellular carcinoma progression.
Yongping Lai, Fei Wang, Guang Cai, Yingying Li, Jiaxin Weng, Bixing Zhao

Front Immunol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: clinical implications.
Bixing Zhao, Yang Zhou, Niangmei Cheng, Xiaoyuan Zheng, Geng Chen

J Exp Clin Cancer Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Targeted Inhibition of PDGFRA with avapritinib, markedly enhances lenvatinib efficacy in hepatocellular carcinoma in vitro and in vivo: clinical implications.
Bixing Zhao, Yang Zhou, Niangmei Cheng, Xiaoyuan Zheng, Geng Chen

J Exp Clin Cancer Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced glutathione enhances adipose tissue-derived mesenchymal stem cell engraftment efficiency for liver fibrosis by targeting TGFβ1/SMAD3/NOX4 pathway.
Shaoxiong Yu, Yingchao Wang, Yingjun Shi, Saihua Yu, Bixing Zhao

Bioeng Transl Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lnc-PIK3R1, transcriptionally suppressed by YY1, inhibits hepatocellular carcinoma progression via the Lnc-PIK3R1/miR-1286/GSK3β axis.
Peng Lyu, Fengyue Li, Runzhi Deng, Qiliang Wei, Bingkai Lin, Bixing Zhao

Biochim Biophys Acta Mol Basis Dis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circular RNA-based neoantigen vaccine for hepatocellular carcinoma immunotherapy.
Fei Wang, Guang Cai, Yingchao Wang, Qiuyu Zhuang, Zhixiong Cai, Bixing Zhao

MedComm (2020)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chalcomoracin promotes apoptosis and endoplasmic reticulum stress in hepatocellular carcinoma cells.
Yongliang Cui, Liqin Lan, Jiahui Lv, Bixing Zhao, Jinfeng Kong

J Antibiot (Tokyo)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRISPR/Cas12b assisted loop-mediated isothermal amplification for easy, rapid and sensitive quantification of chronic HBV DNA in one-pot.
Haipo Xu, Gengping Lin, Ronghua Chen, Zhixiong Cai, Yupeng Sun, Bixing Zhao

Anal Chim Acta· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lnc-CCNH-8 promotes immune escape by up-regulating PD-L1 in hepatocellular carcinoma.
Bixing Zhao, Xiaoyuan Zheng, Yang Wang, Niangmei Cheng, Yue Zhong

Mol Ther Nucleic Acids· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pien Tze Huang Inhibits Migration and Invasion of Hepatocellular Carcinoma Cells by Repressing PDGFRB/YAP/CCN2 Axis Activity.
Zhi-Yi Luo, Qi Tian, Niang-Mei Cheng, Wen-Han Liu, Ye Yang, Bi-Xing Zhao

Chin J Integr Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNA Methyltransferase FTSJ3 Regulates the Type I Interferon Pathway to Promote Hepatocellular Carcinoma Immune Evasion.
Qiuyu Zhuang, Zhiguo Dai, Xuechun Xu, Shaoyi Bai, Yindan Zhang, Bixing Zhao

Cancer Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hsa_circ_0001687 Function as a ceRNA to Facilitate Hepatocellular Carcinoma Progression miR-140- 3p/FOXQ1 Axis.
Song You, Niangmei Cheng, Fei Wang, Xiaoyuan Zheng, Yingchao Wang, Bixing Zhao

Protein Pept Lett· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia induces hepatocellular carcinoma metastasis via the HIF-1α/METTL16/lnc-CSMD1-7/RBFOX2 axis.
Yingchao Wang, Yong Yang, Ye Yang, Yuan Dang, Zhiting Guo, Bixing Zhao

iScience· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lnc-PLA2G4A-4 facilitates the progression of hepatocellular carcinoma by inducing versican expression via sponging miR-23b-3p.
Jiahui Xiong, Yongping Lai, Niangmei Cheng, Jizhe Liu, Fei Wang, Bixing Zhao

Heliyon· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LncRNA TIALD contributes to hepatocellular carcinoma metastasis via inducing AURKA lysosomal degradation.
Yingchao Wang, Yue Zhong, Xiaoyuan Zheng, Niangmei Cheng, Yong Yang, Bixing Zhao

Cell Death Discov· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Universal two-dimensional labelled probe-mediated melting curve analysis based on multiplex PCR for rapid typing of Plasmodium in a single closed tube.
Haipo Xu, Yupeng Sun, Xiaolong Zhang, Ronghua Chen, Zhixiong Cai, Bixing Zhao

Microb Biotechnol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetically responsive nanoplatform targeting circRNA circ_0058051 inhibits hepatocellular carcinoma progression.
Song You, Zijin Luo, Niangmei Cheng, Ming Wu, Yongping Lai, Bixing Zhao

Drug Deliv Transl Res· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long non-coding RNA COX7C-5 promotes hepatocellular carcinoma progression via miR-581/ZEB2 axis.
Yantin Lin, Fei Wang, Yue Zhong, Niang Mei Cheng, Jiahui Xiong, Bixing Zhao

Cell Signal· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADAR1-Mediated RNA Editing and Its Role in Cancer.
Jizhe Liu, Fei Wang, Yindan Zhang, Jingfeng Liu, Bixing Zhao

Front Cell Dev Biol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Far-Red Light Triggered Production of Bispecific T Cell Engagers (BiTEs) from Engineered Cells for Antitumor Application.
Cuilin Zhang, Yingjun Shi, Lingjie Wu, Chenyi Wang, Naishun Liao, Bixing Zhao

ACS Synth Biol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vivo Tracking of Cell Viability for Adoptive Natural Killer Cell-Based Immunotherapy by Ratiometric NIR-II Fluorescence Imaging.
Naishun Liao, Lichao Su, Youshi Zheng, Bixing Zhao, Ming Wu

Angew Chem Int Ed Engl· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A remotely controlled NIR-II photothermal-sensitive transgene system for hepatocellular carcinoma synergistic therapy.
Shuangying Qiao, Fuli Xin, Ming Wu, Youshi Zheng, Bixing Zhao

J Mater Chem B· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Prognostic Evaluation Model to Predict the Overall Survival and Early Recurrence of Hepatocellular Carcinoma.
Yue Zhong, Yong Yang, Lei He, Yang Zhou, Niangmei Cheng, Bixing Zhao

J Hepatocell Carcinoma· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis